News on EMD Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated EMD Pharmaceuticals news from BioPortfolio.com Tue, 09 Feb 2010 23:56:32 GMT en Despite FDA's Letter to Merck Serono, Oral Cladribine is Still Expected to be the First Oral Disease-Modifyinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974344&HITNO=0&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974344&THISHREF=http://c.moreover.com/click/here.pl%3fz2503428553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974344&HITNO=0&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974344&THISHREF=http://c.moreover.com/click/here.pl%3fz2503428553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRehab Manegement: FDA Review of HIV Lipodystrophy Drug Is Delayedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967133&HITNO=1&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967133&THISHREF=http://c.moreover.com/click/here.pl%3fz2499454665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967133&HITNO=1&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967133&THISHREF=http://c.moreover.com/click/here.pl%3fz2499454665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAIDSmeds: No Way to Hide This Drug Approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958652&HITNO=2&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958652&THISHREF=http://c.moreover.com/click/here.pl%3fz2495485052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958652&HITNO=2&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958652&THISHREF=http://c.moreover.com/click/here.pl%3fz2495485052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool via MSN Money: Tysabri Updates: All You Have to Do Is Askhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958620&HITNO=3&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958620&THISHREF=http://c.moreover.com/click/here.pl%3fz2495472841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958620&HITNO=3&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958620&THISHREF=http://c.moreover.com/click/here.pl%3fz2495472841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool via MSN Money: No Way to Hide This Drug Approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958613&HITNO=4&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958613&THISHREF=http://c.moreover.com/click/here.pl%3fz2495469815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958613&HITNO=4&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958613&THISHREF=http://c.moreover.com/click/here.pl%3fz2495469815%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool: Tysabri Updates: All You Have to Do Is Askhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958595&HITNO=5&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958595&THISHREF=http://c.moreover.com/click/here.pl%3fz2495458958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958595&HITNO=5&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958595&THISHREF=http://c.moreover.com/click/here.pl%3fz2495458958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMotley Fool: Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New Englandhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954195&HITNO=6&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954195&THISHREF=http://c.moreover.com/click/here.pl%3fz2492553828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954195&HITNO=6&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954195&THISHREF=http://c.moreover.com/click/here.pl%3fz2492553828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Idera obtains clinical milestone under collaboration with Merckhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952334&HITNO=7&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952334&THISHREF=http://c.moreover.com/click/here.pl%3fz2490743393%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952334&HITNO=7&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952334&THISHREF=http://c.moreover.com/click/here.pl%3fz2490743393%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDatamonitor: Two-Year Results From CLARITY Study With Cladribine Tablets In Multiple Sclerosis Published In The New England Journal Of Medicinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953198&HITNO=8&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953198&THISHREF=http://c.moreover.com/click/here.pl%3fz2491327133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953198&HITNO=8&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953198&THISHREF=http://c.moreover.com/click/here.pl%3fz2491327133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Medical News: Two-Year Results From CLARITY Study With Cladribine Tablets In Multiple Sclerosis Published In The New England Journal Of Medicinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953071&HITNO=9&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953071&THISHREF=http://c.moreover.com/click/here.pl%3fz2491222352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953071&HITNO=9&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953071&THISHREF=http://c.moreover.com/click/here.pl%3fz2491222352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947194&HITNO=10&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947194&THISHREF=http://c.moreover.com/click/here.pl%3fz2487915400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947194&HITNO=10&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947194&THISHREF=http://c.moreover.com/click/here.pl%3fz2487915400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: Idera Pharmaceuticals Reaches Clinical Milestone under Its Collab...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939421&HITNO=11&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939421&THISHREF=http://c.moreover.com/click/here.pl%3fz2484621100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939421&HITNO=11&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939421&THISHREF=http://c.moreover.com/click/here.pl%3fz2484621100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Idera Pharma achieves clinical milestone under its collaboration with Merck for cancer treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941115&HITNO=12&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941115&THISHREF=http://c.moreover.com/click/here.pl%3fz2485333846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941115&HITNO=12&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941115&THISHREF=http://c.moreover.com/click/here.pl%3fz2485333846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Idera obtains clinical milestone under collaboration with Merckhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943415&HITNO=13&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943415&THISHREF=http://c.moreover.com/click/here.pl%3fz2486103625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943415&HITNO=13&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943415&THISHREF=http://c.moreover.com/click/here.pl%3fz2486103625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Idera obtains clinical milestone under collaboration with Merckhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940910&HITNO=14&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940910&THISHREF=http://c.moreover.com/click/here.pl%3fz2485263906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940910&HITNO=14&MSIZE=167&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=EMD%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940910&THISHREF=http://c.moreover.com/click/here.pl%3fz2485263906%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: